Daniel Spratt, MD, Professor of Radiation Oncology at University of Michigan provides his perspective on these clinical trials and the implications for patient management
Пікірлер: 1
@heinhtetnaing3389 Жыл бұрын
Handsome and smart doctor. But this channel has little marketing sense.